NDC 49702-246 – Dovato
Dolutegravir Sodium 50 mg/1; Lamivudine 300 mg/1 · Tablet, Film Coated · Oral
Product NDC49702-246
Product details
- Brand name
- Dovato
- Generic name
- dolutegravir sodium and lamivudine
- Labeler
- ViiV Healthcare Company
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA211994
- Marketed since
- April 8, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Dolutegravir Sodium 50 mg/1
- Lamivudine 300 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 49702-246-13 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-246-13) | Apr 8, 2019 |
| 49702-246-33 | 1 BLISTER PACK in 1 CARTON (49702-246-33) / 30 TABLET, FILM COATED in 1 BLISTER PACK | Jan 1, 2024 |
| 49702-246-62 | 1 BLISTER PACK in 1 CARTON (49702-246-62) / 14 TABLET, FILM COATED in 1 BLISTER PACK | Jan 1, 2024 |